Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss ...
WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...
WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...
WeightWatchers announced Friday that CEO Sima Sistani has stepped down from the job and is no longer on the company's board after 2½ years leading the weight loss company. Sistani has been ...
The weight-loss company, previously championed by the likes of Oprah Winfrey, saw its stock spike this week after announcing that it will make copycats of Novo Nordisk's (NVO) Ozempic and Wegovy ...
The New York-based weight loss company didn't reveal the reasons behind the abrupt move, but it noted that Comonte would step into the role of CEO at a time when the company is “focused on ...
Soaring demand for weight-loss drugs such as Wegovy and Eli Lilly's (LLY.N), opens new tab Zepbound, shown to help patients lose as much as 20% of weight on average, has led to shortages that ...
Tara Comonte, a WeightWatchers board member and former Shake Shack executive, was made interim chief executive. The New ...